Research & Development
22 January 2019 - - US-based Attention Deficit Hyperactivity Disorder treatments provider Ironshore Pharmaceuticals, Inc., a wholly owned subsidiary of Highland Therapeutics Inc., has appointed D...
21 January 2019 - RNAi therapeutics company OliX Pharmaceuticals Inc (Kosdaq:226950) said on Friday that it has nominated OLX10020 as the clinical candidate for the treatment of Geographic Atrophy (GA...
21 January 2019 - AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced on Friday an update on the Phase three RESOLVE trial (PCYC-1137) of ibrutinib (IMBRUVICA) in combina...
21 January 2019 - Acrotech Biopharma, a subsidiary of Aurobindo Pharma, has agreed to acquire seven FDA-approved haematology/oncology products from Spectrum Pharmaceuticals, it was reported on Friday....
18 January 2019 - - US-based commercial-stage biopharmaceutical company Omeros Corp. (NASDAQ: OMER) has finalised its clinical plan for OMS721 submission and approval in immunoglobulin A nephropathy f...
18 January 2019 - Biotechnology company Spectrum Pharmaceuticals Inc (NASDAQ-GS:SPPI) revealed on Thursday the launch of a definitive agreement to divest its portfolio of seven products to Acrotech Bi...